First published 10/3/2026, 9:12:15 PM · Last updated 10/3/2026, 9:12:15 PM

Validation of an Endometrial Tumor Diameter Model for Risk Assessment in the Absence of Lymph Node Mapping

A journal article reports validation of a model that uses endometrial tumor diameter to assess risk when lymph node mapping is not performed. The item is published by Aurora Health Care, Inc. on 2020-10-23.

Illustrative image: Endometrial Adenocarcinoma Longitudinal section through hysterectomy specimen. Fundus at top; lower uterine segment at bottom. Cervix not included. Endometrial cavity at the left, surface of tumor top left, parametrium at the right, bottom right very extensive adenomyosis. See: https://www.flickr.com/photos/euthman/193356032/in/set-72057594114099781/ — Ed Uthman, MD./Wikimedia Commons, CC BY 2.0

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

Validated risk-assessment tools can inform clinical decision-making for endometrial cancer patients without lymph node mapping.

Sources

Validation of an Endometrial Tumor Diameter Model for Risk Assessment in the Absence of Lymph Node MappingMetadata provided by Crossref. Usage terms

Report an issue